Diadenosine polyphosphates in the central nervous system

Neuroscience Research Communications

Volumn 20, Issue 2, 1997, Pages 69-78

  Pintor, Jesús ^a   Hoyle, Charles H V ^b   Gualix, Javier ^a   Miras Portugal, M Teresa ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Adenine dinucleotides; Ap4A; Ap5A; Dinucleotide receptors; P2 receptors; Purinergic system

Indexed keywords

ADENOSINE; ADENOSINE RECEPTOR; CALCIUM ION; CYCLIC AMP DEPENDENT PROTEIN KINASE; DINUCLEOTIDE; PHOSPHOPROTEIN PHOSPHATASE; POLYPHOSPHATE; PROTEIN KINASE C; PURINE P2 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE;

AUTORADIOGRAPHY; BEHAVIOR; CALCIUM TRANSPORT; CENTRAL NERVOUS SYSTEM; CEREBELLUM; EXTRACELLULAR SPACE; FACIAL NERVE NUCLEUS; MOTOR ACTIVITY; NERVE STIMULATION; NONHUMAN; OLFACTORY BULB; RECEPTOR BINDING; REVIEW; SENSORY NERVE; SUPERIOR OLIVARY NUCLEUS; SYNAPSE;

EID: 0030988931     PISSN: 08936609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6769(199703)20:2<69::AID-NRC187>3.0.CO;2-Y     Document Type: Review

References (53)

1. Abbracchio, M.P. and Burnstock, G. (1994) Pharmacol.Ther. 64, 445.
2. Balkar, V.J., Li, Y., Killinger, S. and Bennett, M.R. (1995) Brit.J.Pharmacol. 115, 302.
3. Bo, X. and Burnstock, G. (1994) Neuroreport 5, 1601.
4. Bo, X., Zhang, Y, Nassar, M., Burnstock G. and Schoepfer, R. (1995) FEBS Lett. 375, 129.
5. Brake, A.J., Wagenbach, M.J. and Julius D. (1994) Nature 371, 519.
6. Burnstock, G. (1996) In: P2 receptors: Localization, function and transduction mechanisms, D.J. Chadwick and J.A. Goode (eds). J. Wiley & Sons, Chichester, England, p. 1.
7. Cunha, R.A., Ribeiro, J.A. and Sebastiao, A.M. (1994) Eur.J.Neurosci. 6, 33.
8. Flodgaard, H. and Klenow H. (1982) Biochemical J. 208, 737.
9. Giros, B., Jaber, M., Jones, S.R., Wightman, R.M. and Caron M.G. (1996) Nature 379, 606.
10. Gualix, J., Abal, M., Pintor, J., García-Carmona, F. and Miras-Portugal, M.T. (1996) J. Biol. Chem. 271, 1957.
11. Gualix, J., Fideu, D., Pintor, J., Alvarez, A. and Miras-Portugal, M.T. (1996) Drug Dev. Res. 37, 148S.
12. Hilderman, R.H., Lilien, J.E., Zimmerman, J.K., Tate, D.H., Dimmick, M.A. and Jones G.B. (1994) Biochem. Biophys. Res. Commun. 200, 749.
13. Hilderman, R.H., Martin, M., Zimmerman, J.K. and Pivorun E.B. (1991) J.Biol.Chem. 266, 6915.
14. Hoyle, C.H.V. (1990) Gen. Pharmacol. 21, 827.
15. Hoyle, C.H.V., Knight, G.E. and Burnstock, G. (1990) Brit.J.Pharmacol. 99, 617.
16. Hoyle, C.H.V., Ziganshin, A.U., Pintor, J. and Burnstock G. (1996) Brit.J.Pharmacol. 118, 1294.
17. Illes, P., Nieber, K., Frohlich, R. and Norenberg W. (1996) In: P2 receptors: Localization, function and transduction mechanisms, D.J. Chadwick and J.A. Goode (eds). J. Wiley & Sons, Chichester, England, p. 110.
18. Jovanovic, A. and Terzic, A. (1996) Brit.J.Pharmacol 117, 233.
19. King, B.F., Pintor J., Wang, S., Ziganshin, A.U., Ziganshina, L.E. and Burnstock, G. (1996) J.Pharmacol.Exp.Ther. 276, 93.
20. King, B.F., Ziganshina, L.E., Pintor J. and Burnstock, G. (1996) Brit.J.Pharmacol. 117, 1371.
21. Klishin, A., Lozovaya, N., Pintor, J., Miras-Portugal, M.T. and Krishtal, O.A. (1994) Neuroscience 58, 235.
22. Luthje J. and Ogilvie, A. (1983) Biochem. Biophys. Res. Commun. 115, 253.
23. Mateo, J., Rotllán, P. and Miras-Portugal, M.T. (1996) Brit.J.Pharmacol 119, 1.
24. 4A and other dinucleoside polyphosphates, A.G. McLennan (ed). CRC Press, Boca Raton, USA.
25. Nordone, A.J. and Pivorun, E.B. (1995) Pharmacol. Biochem. Behav. 52, 85.
26. Panchenko., V., Pintor, J., Tsyndrenko, Ya., Miras-Portugal, M.T. and Krishtal, O.A. (1996) Neuroscience 70, 353.
27. Pintor. J. and Miras-Portugal, M.T. (1993) Drug Develop.Res. 28, 259.
28. Pintor. J. and Miras-Portugal, M.T. (1995) Brit.J.Pharmacol. 115, 895.
29. Pintor. J. and Miras-Portugal, M.T. (1995) Gen. Pharmacol. 26, 229.
30. Pintor. J., Diaz-Rey, M.A. and Miras-Portugal, M.T. (1993) Brit.J.Pharmacol. 108, 1094.
31. Pintor J., Diaz-Rey, M.A., Torres, M. and Miras-Portugal, M.T. (1992) Neurosci.Lett. 136, 114.
32. Pintor. J., King, B.F., Miras-Portugal, M.T. and Burnstock, G. (1996) Brit.J.Pharmacol. 119, 1006.
33. Pintor. J., Kowalewski, H.J., Torres M., Miras-Portugal, M.T. and Zimmermann H. (1992) Neurosci.Res.Commun. 10, 9.
34. Pintor. J., Porras, A., Mora, F. and Miras-Portugal, M.T. (1993) Neurosci.Lett. 150, 13.
35. Pintor. J., Porras, A., Mora, F. and Miras-Portugal, M.T. (1995) J.Neurochem. 64, 670.
36. Pintor. J., Rotllan, P., Torres M. and Miras-Portugal, M.T. (1992) Anal.Biochem. 200, 296.
37. Pintor. J., Torres, M. and Miras-Portugal, M.T. (1991) Life Sci. 48, 2317.
38. Pivorun, E.B. and Nordone, A. (1996) J.Neurosci.Res. 44, 478.
39. Ramos, A., Pintor, J., Miras-Portugal, M.T. and Rotllán, P. (1995) Anal. Biochem. 228, 74.
40. Ripoll. C., Martin, F., Rovira, J.M., Pintor, J., Miras-Portugal, M.T. and Soria, B. (1996) Diabetes 45, 1431.
41. Rodriguez del Castillo, A., Torres, M. Delicado, E.G. and Miras-Portugal. M.T. (1988) J.Neurochem, 51, 1696.
42. Rodriguez-Pascual, F., Cortes, R., Torres, M., Palacios, J.M. and Miras-Portugal, M.T. (1996) Neuroscience, in press.
43. Rodriguez-Pascual, F., Torres, M., Rotllán, P. and Miras-Portugal, M.T. (1992) Arch Biochem. Biophys., 297, 176.
44. Schlutter, H., Offers, E., Bruggemann, G., Van der Giet, M., Tepel, M., Nordhoff, E., Karas, M., Spieker, C., Witzel, H. and Zidek, W. (1994) Nature 367, 186.
45. Schubert, P., Pintor, J. and Miras-Portugal, M.T. (1995) In: Adenosine and adenine nucleotides: from molecular biology to integrative physiology, L. Bellardinely and A. Pelleg (eds). Kluwer Academic Publishers, Boston, USA, p. 281.
46. Shinozuka, K., Bjur, R.A. and Westfall, D.P. (1990) J.Pharmacol.Exp.Ther. 254, 900.
47. Stone T.W. and Perkins M.N. (1981) Brain Res. 229, 241.
48. Suprenant, A. (1996) In: P2 receptors: Localization, function and transduction mechanisms, D.J. Chadwick and J.A. Goode (eds). J. Wiley & Sons, Chichester, England, p. 208.
49. Valera, S., Hussy, N. Evans, R.J., Adami, N., North, R.A., Suprenant, A. and Buell, G. (1994) Nature 371, 516.
50. von Kugelgen, I., Spath, L. and Starke, K. (1994) Brit.J.Pharmacol. 113, 815.
51. Walker, J., Lewis, T.E., Pivorun, E.B. and Hilderman, R.H. (1993) Biochemistry 32, 3119.
52. Webb, T.E., Simon, J., Krishek, B.J., Bateson, A.N., T.G., King B.F., Burnstock G. and Barnard, E.A. (1993) FEBS Lett. 324, 219.
53. Zimmermann, H. (1996). Prog. Neurobiol. 49, 589.